Thermo Fisher Scientific (NYSE:TMO) is expanding one of its plants in North Carolina, according to news reports.
Lab Instruments & Supplies
Robert Langer joins Millipore’s board
MIT professor Robert Langer will bring his impressive resume to the board of Millipore Corp. (NYSE:MIL), replacing Daniel Bellus, who will step down in March, 200, after nearly 10 years on the company’s board.
The Billerica, Mass.-based lab equipment maker said Langer will become a member of its governance and public policy and technology committees.
Langer’s resume includes more than 750 issued patents, 1,050 articles, seats on the board of multiple start-ups and a 2006 National Medal of Science for his pioneering work in tissue regeneration and the use of polymers for the controlled release of medicines.
Dirk Laukien sells off more of his Bruker stake
Outgoing Bruker Biospin co-president and founding family member Dirk Laukien liquidated about 10 percent of his personal holdings in Bruker Corp. (NSDQ:BRKR), pocketing more than $21 million.
The transaction took place during the first week of December, according to securities filings, when Laukien sold 2 million shares priced at $10.67 per share, for a total of $21.3 million.
Caliper closes Xenogen Biosciences small animal deal, lowers Q4 guidance
Caliper Life Sciences Inc. (NSDQ:CALP) closed an $11 million deal to sell Xenogen Biosciences Corp. to Taconic Farms Inc. and lowered its fourth-quarter guidance as a result.
The Hopkinton, Mass.-based lab equipment and services provider acquired XenBio subsidiary, which supplies genetically altered small animals to drug developers, when it bought Xenogen Corp. in 2006. About 90 percent of the business involves selling genetically engineered rodents called “light producing transgenic animals,” which have been modified to produce substances that fluoresce when examined using special imaging equipment, according to Caliper’s website.
Microfluidics chairman Little to step down
Microfluidics International Corp. (OTC:MFLU) chairman James Little plans to step down at the end of the year.
The Newton, Mass.-based high-shear fluid processor maker said Little, who’s served on the board since 1995 and has been chairman since 2007, will be replaced by George Uveges when he retires Dec. 31.
Cell Biosciences acquires Protein Forest
Cell Biosciences Inc. acquired Protein Forest Inc. for an undisclosed amount, adding the Lexington, Mass.-based sample preparation technology firm’s ProteomeChip product line to its roster of protein analysis technologies.
Protein Forest‘s digital product line is used to fractionate proteins from complex biological samples used in proteomics research. Santa Clara, Calif.-based Cell Biosciences said ProteomeChip can be used at the front end of sample preparation with a variety of techniques, including its own nanoproteomic platforms.
MassDevice Q&A: Thermo Fisher Scientific CEO Marc Casper
To outside observers, Marijn Dekkers’ departure from the corner office at Thermo Fisher Scientific (NYSE:TMO) might have seemed abrupt. After a seven-year run during which he led a profound re-shaping of the laboratory equipment and supplies manufacturer (and boosted revenues from the $2 billion range to about $10.5 billion a year), Dekkers resigned as CEO of the Waltham, Mass.-based firm to take the helm at German pharma giant Bayer AG.
Millipore buys out Indian joint venture
Millipore Corp. (NYSE:MIL) bought out the remaining 60 percent stake in its Indian subsidiary for an undisclosed amount.
The Billerica, Mass.-based lab instruments maker said the deal is part of its push into developing markets in Brazil, Russia, India, China and Singapore. Citing the more than 80 plants in India with U.S. Food & Drug Administration clearance to manufacture pharmaceuticals, Millipore said the country makes 25 percent of the world’s generic drugs.
Pressure BioSciences sells equity units for $1 million
Pressure BioSciences Inc. (PBIO) completed the initial tranche of a new funding round, pocketing nearly $1.2 million through the sale of equity units.
In all, the Easton, Mass.-based pressure cycling device manufacturer expects to generate $2.5 million in proceeds from the sale of units consisting of non-voting Series B convertible preferred stock and warrants to purchase additional shares at $23.80 a share. Each preferred share can be converted into 10 shares of PBIO common stock.
Pressure BioSciences shares closed yesterday at $1.43 each.
PerkinElmer inks development deal with Gilson Inc.
PerkinElmer Inc. (PKI) and Gilson Inc. signed a development deal that will see the Waltham, Mass.-based diagnostics and lab equipment maker create a mass spectrometer for Gilson’s liquid chromatography and solid phase extraction devices.
PerkinElmer and Middleton, Wis.-based Gilson said the deal calls for PKI to develop a dedicated single quadrupole mass spectrometer that Gilson will integrate into its preparative chromatography systems.
Pressure BioSciences’ Q3 revenues rise, net losses fall
Pressure BioSciences Inc. (PBIO) is almost ready to pop.
Executives at the Easton, Mass.-based manufacturer, which is marketing high-pressure devices to control bio-molecular interactions, said they anticipate soon signing a strategic marketing and distribution agreement with a large, multi-national life sciences company. They also are continuing to work on deals addressing the company’s capital needs.